Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Embla Medical hf Director's Dealing 2016

May 19, 2016

8210_rns_2016-05-19_0fa0e215-7e3b-4867-838b-2e3f14c65e78.html

Director's Dealing

Open in viewer

Opens in your device viewer

Ossur Hf : insider trading

Ossur Hf : insider trading

                                          Announcement Össur hf. No. 52/2016

Auðkenni útgefanda/Trade ticker:

OSSR

Nafn útgefanda/Issuer:

Össur hf.

Dagsetning tilkynningar/Date of announcement:

19 May 2016

Nafn fruminnherja/Name primary insider:

Jos van Poorten

Tengsl fruminnherja við útgefanda/Insider's relation with the issuer:

Managing Director of EMEA

Dagsetning viðskipta/Date of transaction:

19 May 2016

Tímasetning viðskipta/Time of transaction:

12:28 CET

Tegund fjármálagernings/Type of financial instrument:

Equities

Kaup eða sala/Buy or Sell:

Buy

Fjöldi hluta/Number of shares:

163,793

Verð pr. Hlut/Price per share:

DKK 7.86

Fjöldi hluta í eigu fruminnherja eftir viðskipti/Primary insider's holdings
after the transaction:

165,212

Fjöldi hluta sem fruminnherji á kauprétt að/Primary insider's option holdings
after the transaction:

200,000

Fjöldi hluta fjárhagslega tengdra aðila eftir viðskipti/Related parties'
holdings after the transaction:

0

Dagsetning lokauppgjörs*/Date of settlement*:

23 May 2016

Athugasemdir*/Comments*:

Settlement of share option agreement with Össur hf., dated 8 February 2013

[HUG#2013932]